Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table 2 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
  1. Home
  2. Publications
  3. Supplementary Table 2 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma

Supplementary Table 2 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma

Authors:
  • DKDuygu Kuzuoglu-Ozturk
    Duygu Kuzuoglu-Ozturk
  • OAOzlem Aksoy
    Ozlem Aksoy
  • CSChristin Schmidt
    Christin Schmidt
  • RLRobin Lea
    Robin Lea
  • JLJon D. Larson
    Jon D. Larson
  • RPRyan R.L. Phelps
    Ryan R.L. Phelps
  • NNNicole Nasholm
    Nicole Nasholm
  • MHMegan Holt
    Megan Holt
  • ACAdrian Contreras
    Adrian Contreras
  • MHMiller Huang
    Miller Huang
  • SWShannon Wong-Michalak
    Shannon Wong-Michalak
  • HSHao Shao
    Hao Shao

Open Access
Publisher website
Google Scholar
  • 31 March 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/0008-5472.22432718.v1
Abstract
RPF abundance of Rapalink-1 and Rapamycin treated samples
Keywords
  • MEDULLOBLASTOMA
  • RPF
  • TRANSLATION
  • ABUNDANCE
  • RAPALINK
  • RAPAMYCIN
  • SUPPLEMENTARY TABLE
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.